This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Zacks Analyst Blog Highlights: BGS, MNST, MED, NUS and FLO
by Zacks Equity Research
The Zacks Analyst Blog Highlights: BGS, MNST, MED, NUS and FLO
The Zacks Analyst Blog Highlights: Noble Energy, TopBuild, Nu Skin, Bonanza Creek and Ollie's Bargain
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Noble Energy, TopBuild, Nu Skin, Bonanza Creek and Ollie's Bargain
The Zacks Analyst Blog Highlights: Meritage Homes, PulteGroup, Silgan, D.R. Horton and Nu Skin
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Meritage Homes, PulteGroup, Silgan, D.R. Horton and Nu Skin
5 Consumer Staples Stocks to Beat on Earnings Amid Coronavirus
by Zacks Equity Research
Amid coronavirus crisis, players in the Consumer Staples sector are gaining from rising demand on stockpiling. We bring five stocks with earnings beat potential.
Here's How Beyond Meat (BYND) is Placed Ahead of Q2 Earnings
by Zacks Equity Research
Beyond Meat's (BYND) second-quarter results are likely to reflect strength in the retail business due to higher at-home consumption, while the foodservice business may remain under pressure.
Service Corporation (SCI) Q2 Earnings Top Estimates, Rise Y/Y
by Zacks Equity Research
Service Corporation's (SCI) second-quarter 2020 results reflect higher earnings and sales, courtesy of increased funeral services performed amid the pandemic and solid cost control.
Top 5 Consumer Staple Stocks Ahead of Q2 Earnings Results
by Nalak Das
The consumer staples sector has so far reported relatively better results despite the decline of overall sector's earnings year over year.
Nu Skin Enterprises (NUS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
Nu Skin (NUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: NUS, AN, ROK, CSCO and FLT
by Zacks Equity Research
Zacks.com featured highlights include: NUS, AN, ROK, CSCO and FLT
5 Top-Ranked Value Stocks With Double-Digit Returns in July
by Nalak Das
At this stage, it would be prudent to pick up value stocks with a favorable Zacks Rank that popped in July and still have momentum.
5 Must-Buy Growth Stocks Set to Beat Q2 Earnings Estimates
by Nalak Das
Although earnings growth is negative year over year, a handful of growth stocks with a favorable Zacks Rank are set to beat Q2 earnings estimates.
Altria's (MO) Q2 Earnings Beat Estimates, Revenues Down Y/Y
by Zacks Equity Research
Altria's (MO) second-quarter 2020 results reflect adjusted OCI growth in oral tobacco and smokeable product segments. However, smokeable product revenues decline.
Will Tyson Foods' (TSN) Q3 Earnings Reflect Coronavirus Woes?
by Zacks Equity Research
Tyson Foods' (TSN) third-quarter results are likely to reflect soft foodservice volumes and elevated cost of production due to the coronavirus pandemic.
5 Top-Ranked Stocks With Upgraded Broker Ratings to Buy Now
by Swayta Shah
When brokers upgrade a stock, you can rely on their judgment. Nonetheless, you should also take into account some other factors to ensure steady returns.
Factors Likely to Impact Pilgrim's Pride's (PPC) Q2 Earnings
by Zacks Equity Research
Macroeconomic headwinds in Mexico and high input costs are likely to get reflected in Pilgrim's Pride's (PPC) Q2 performance. Nevertheless, strength in Prepared Foods unit bodes well.
Here's How Kraft Heinz (KHC) Looks Ahead of Q2 Earnings
by Zacks Equity Research
Increased demand owing to higher at-home consumption amid the coronavirus outbreak is likely to get reflected in Kraft Heinz's (KHC) second-quarter 2020 performance.
Kellogg (K) to Report Q2 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Kellogg's (K) second-quarter results are likely to reflect high demand amid pandemic-led increased at-home consumption. However, adverse impacts of divestitures and currency volatility are concerns.
Here's How B&G Foods (BGS) Looks Just Ahead of Q2 Earnings
by Zacks Equity Research
B&G Foods' (BGS) second-quarter results are likely to reflect higher demand amid coronavirus-led increased at-home consumption. Also, the company's pricing strategy and saving efforts bode well.
Clorox (CLX) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Clorox (CLX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Corornavirus-Led Store Closures Hurt Inter Parfums' Q2 Sales
by Zacks Equity Research
Inter Parfums' (IPAR) sales decline year-over-year across all brands and geographies in second-quarter 2020, thanks to coronavirus-led store closures.
Here's How Lamb Weston (LW) Looks Just Ahead of Q4 Earnings
by Zacks Equity Research
Lamb Weston's (LW) fourth-quarter show is likely to reflect adverse impacts of low traffic at restaurants amid the pandemic. However, high demand from retailers is likely to have aided performance.
Here's How Mondelez (MDLZ) Looks Ahead of Q2 Earnings
by Zacks Equity Research
Impacts of higher customer service, labor and logistics costs are likely to get reflected in Mondelez's (MDLZ) second-quarter 2020 performance.
Here's How Altria (MO) is Placed Just Ahead of Q2 Earnings
by Zacks Equity Research
Altria Group's (MO) second-quarter 2020 results are likely to reflect pricing gains. However, cigarette volumes have been affected by regulatory hurdles and rising health consciousness.
NUS or HELE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NUS vs. HELE: Which Stock Is the Better Value Option?
Philip Morris (PM) Q2 Earnings Beat Estimates, Decline Y/Y
by Zacks Equity Research
Philip Morris' (PM) second-quarter 2020 results reflect solid pricing variance. However, adverse volume/mix, mainly due to soft cigarette volumes, weighs on revenues and earnings.